Latest

psychopharmacology

Featured Neuroscience Open Neuroscience Articles Psychology

·July 15, 2019·4 min read

Improved mood and focus reported by microdosers

Microdosing, a growing trend where people take small doses for psychedelic drugs, is associated with improved mood, focus, and creativity. For some, microdosing may provide a possible alternative to SSRI antidepressants. However, researchers warn of some potential problems with microdosing, including negative side effects, psychological stigma, and exposure to elicit, black market products.

Featured Neuroscience Psychology

·July 10, 2019·2 min read

How a popular antidepressant drug could rewire the brain

Fluoxetine rearranges nerve fibers in the hippocampus of mice, a new study reports.

This shows a person with pills in their hand

Featured Neurology Neuroscience Open Neuroscience Articles Psychology

·June 25, 2019·4 min read

Common antidepressants interact with opioid med to lessen pain relief

SSRI antidepressants, such as Prozac and Paxil, interact with opioid medications to make them less effective at providing relief from chronic pain. Tramadol relies on activation of the CYP2D6 enzyme to control pain, but SSRIs inhibit this enzyme. Researchers suggest prescribing different classes of antidepressants which do not suppress the enzyme may benefit those in need of opioid medications. Alternatively, non-opioid pain killers should be considered for those who can not switch from SSRIs.

Featured Neuroscience Psychology

·June 10, 2019·4 min read

Safe to breastfeed while on bipolar meds? Jury’s still out

Previous research into the effects of lithium exposure via breastmilk are poorly designed and sparse, researchers report. Until more research is done, mothers and babies should be reviewed on a case-by-case basis for lithium continuation, as discontinuing the medication could pose a significant risk for both child and parent.

This shows a diagram of how the drug works

Featured Neuroscience Psychology

·June 3, 2019·3 min read

Diabetes drug alleviates anxiety in mice

Metformin, a common diabetes medication, shows promise for the treatment of anxiety and depression.

This shows two heads with a psychedelic background

Featured Neuroscience Open Neuroscience Articles Psychology

·May 30, 2019·4 min read

‘Ecstasy’ shows promise for post-traumatic stress treatment

MDMA shows promise for the treatment of post-traumatic stress disorder. Combining the use of Ecstasy with psychotherapy treatments resulted in a reduction of PTSD symptoms after just one session. 54% of the study participants no longer met the PTSD criteria after two sessions. Patients also reported improvements in depression symptoms.

Featured Neuroscience Open Neuroscience Articles Psychology

·May 21, 2019·5 min read

Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray

Esketamine combined with antidepressants acts rapidly to help alleviate symptoms in those with treatment-resistant depression.

Featured Neuroscience Psychology

·May 16, 2019·5 min read

Ketamine: The illicit party psychedelic that promises to heal depression

Ketamine, an anesthetics which has been commonly used as an illicit party drug, is helping people overcome depression. The drug works rapidly and provides lasting relief from depressive symptoms for weeks after exposure. Researchers are examining how ketamine works in the brain to help positively influence behavior in those with mood disorders.

This shows a blue head and an orange head

Featured Neuroscience Psychology

·April 24, 2019·4 min read

CBD reduces impairment caused by cannabis

Cannabidiol may buffer the effects of THC on the brain for those who use marijuana. Marijuana with a higher CBD content restores disruptions to the salience network caused by THC exposure.

Featured Neuroscience Psychology

·April 23, 2019·2 min read

Texas A&M Research Leads To First Drug For Postpartum Depression

A newly developed drug can help combat the effects of postnatal depression.

This shows how NV-5138 affects dendrites

Featured Neuroscience Open Neuroscience Articles Psychology

·April 17, 2019·3 min read

New drug mimics benefits of ketamine for depression

NV-5138, a small molecule drug that mimics the action of ketamine, provides fast-acting antidepressant responses in rodent models of depression. The drug is currently undergoing Phase 1 testing in humans.

Featured Neuroscience Open Neuroscience Articles Psychology

·April 11, 2019·3 min read

Ketamine reverses neural changes underlying depression-related behaviors: Mouse study

The formation of prefrontal cortex dendritic spine formation sustains the remission of depressive related symptoms and behaviors following ketamine treatment by restoring lost spines.

1 … 26 27 28 29 30 … 41

psychopharmacology

Improved mood and focus reported by microdosers

How a popular antidepressant drug could rewire the brain

Common antidepressants interact with opioid med to lessen pain relief

Safe to breastfeed while on bipolar meds? Jury’s still out

Diabetes drug alleviates anxiety in mice

‘Ecstasy’ shows promise for post-traumatic stress treatment

Study supports effectiveness of new fast-acting antidepressant, esketamine nasal spray

Ketamine: The illicit party psychedelic that promises to heal depression

CBD reduces impairment caused by cannabis

Texas A&M Research Leads To First Drug For Postpartum Depression

New drug mimics benefits of ketamine for depression

Ketamine reverses neural changes underlying depression-related behaviors: Mouse study

3D-Printed “Honeycomb” Sensors Match Your Unique Neural Map

Glutathione Prevents Cellular Clogs

Cortisol Kill-Switch: Exercise Rewires Stress Biology

AI Restores Voices Through Microscopic Neck Movements

Subscribe